Psychedelics and AI and in 2025 with Dillan DiNardo of Y Combinator-backed Mindstate Design Labs
Update: 2025-01-17
Description
Dillan DiNardo, the founder and CEO of Mindstate Design Labs, a drug development company using AI to enable the precision design of altered states of consciousness joins the podcast to discuss the state of psychedelics, AI, consciousness, why Marc Andreessen hates psychedelics, and the intersection of all these things.
Follow Brom on Twitter: https://twitter.com/therealbrom
Learn more about Mindstate: https://www.mindstate.design/
Brom is the founder of focalpoint partners: https://www.focalpointlp.com/
Comments
In Channel



![Investing in Psychedelic BioTech [August 2025 webinar replay] Investing in Psychedelic BioTech [August 2025 webinar replay]](https://s3.castbox.fm/70/e6/a2/62bd7fa7c470b268bd191f457c0ddd8b62_scaled_v1_400.jpg)















